Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Aaron Seth Kesselheim, M.D.

Co-Author

This page shows the publications co-authored by Aaron Kesselheim and Niteesh Choudhry.
Connection Strength

3.832
  1. Switching generic antiepileptic drug manufacturer not linked to seizures: A case-crossover study. Neurology. 2016 Oct 25; 87(17):1796-1801.
    View in: PubMed
    Score: 0.705
  2. Burden of changes in pill appearance for patients receiving generic cardiovascular medications after myocardial infarction: cohort and nested case-control studies. Ann Intern Med. 2014 Jul 15; 161(2):96-103.
    View in: PubMed
    Score: 0.605
  3. Variations in pill appearance of antiepileptic drugs and the risk of nonadherence. JAMA Intern Med. 2013 Feb 11; 173(3):202-8.
    View in: PubMed
    Score: 0.549
  4. Conflict of interest in oncology publications: a survey of disclosure policies and statements. Cancer. 2012 Jan 01; 118(1):188-95.
    View in: PubMed
    Score: 0.490
  5. The international pharmaceutical market as a source of low-cost prescription drugs for U.S. patients. Ann Intern Med. 2008 Apr 15; 148(8):614-9.
    View in: PubMed
    Score: 0.393
  6. Paying physicians to prescribe generic drugs and follow-on biologics in the United States. PLoS Med. 2015 Mar; 12(3):e1001802.
    View in: PubMed
    Score: 0.159
  7. Prescription drug insurance coverage and patient health outcomes: a systematic review. Am J Public Health. 2015 Feb; 105(2):e17-30.
    View in: PubMed
    Score: 0.157
  8. Availability and utilization of cardiovascular fixed-dose combination drugs in the United States. Am Heart J. 2015 Mar; 169(3):379-386.e1.
    View in: PubMed
    Score: 0.156
  9. Burden of changes in generic pill appearance. Ann Intern Med. 2014 Dec 02; 161(11):840.
    View in: PubMed
    Score: 0.155
  10. The consequences of requesting "dispense as written". Am J Med. 2011 Apr; 124(4):309-17.
    View in: PubMed
    Score: 0.120
  11. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA. 2008 Dec 03; 300(21):2514-26.
    View in: PubMed
    Score: 0.103
  12. Comparative effectiveness of generic versus brand-name antiepileptic medications. Epilepsy Behav. 2015 Nov; 52(Pt A):14-8.
    View in: PubMed
    Score: 0.041
  13. A cross-national comparison of 17 countries' insulin glargine drug labels. Pharmacoepidemiol Drug Saf. 2015 Feb; 24(2):159-65.
    View in: PubMed
    Score: 0.038
  14. Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study. Ann Intern Med. 2014 Sep 16; 161(6):400-7.
    View in: PubMed
    Score: 0.038
  15. Patterns and predictors of generic narrow therapeutic index drug use among older adults. J Am Geriatr Soc. 2013 Sep; 61(9):1586-91.
    View in: PubMed
    Score: 0.036
  16. Changes in direct-to-consumer pharmaceutical advertising following shifts from prescription-only to over-the-counter status. JAMA. 2012 Sep 12; 308(10):973-5.
    View in: PubMed
    Score: 0.033
  17. State generic substitution laws can lower drug outlays under Medicaid. Health Aff (Millwood). 2010 Jul; 29(7):1383-90.
    View in: PubMed
    Score: 0.029
  18. The variability and quality of medication container labels. Arch Intern Med. 2007 Sep 10; 167(16):1760-5.
    View in: PubMed
    Score: 0.024
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.